GlassScriptPhysician profile
Gerard A Collins
NPI 1174726236
$1,667.80
in general payments reported to CMS, 2019-2025
23 companies · $569 in 2025
The $569 reported for 2025 was more than what 75% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $425 · 2020: $50.50 · 2021: $57.77 · 2022: $49.36 · 2023: $144 · 2024: $373 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,086.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,085.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $255.91 | 2019-2024 | Augment Injectable |
| Wright Medical Technology, INC. | $188.30 | 2019-2020 | |
| Abbvie INC. | $112.30 | 2023-2024 | Qulipta, Ubrelvy |
| Smith+Nephew, INC. | $110.91 | 2022-2025 | Stravix Pl, Collagenase Santyl |
| Acera Surgical, INC. | $104.35 | 2025 | Restrata Wound Matrix |
| Amgen INC. | $91.21 | 2024-2025 | Krystexxa |
| Orthofix Medical, INC. | $82.58 | 2024-2025 | Physio-Stim |
| Averitas Pharma INC. | $81.73 | 2024-2025 | Qutenza |
| Avinger INC. | $79.55 | 2019 | |
| Eclipse Technology Solutions INC. | $76.83 | 2023-2025 | |
| Treace Medical Concepts, INC. | $74.06 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $71.12 | 2024 | Tapestry |
| Lifenet Health | $59.90 | 2025 | Theragenesis Wound Matrix |
| Paratek Pharmaceuticals, INC. | $43.45 | 2024-2025 | Nuzyra |
| Kerecis Limited | $43.28 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $36.83 | 2025 | Motoband |
| Vertex Pharmaceuticals Incorporated | $33.75 | 2025 | |
| Bioventus LLC | $31.17 | 2019 | |
| Merck Sharp & Dohme LLC | $23.53 | 2019 | |
| Davol INC. | $21.58 | 2025 | Arista |
| Stimlabs LLC | $19.28 | 2025 | Corplex P |
| Sanofi-Aventis U.S. LLC | $13.85 | 2020 | |
| Novo Nordisk INC | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerard Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.